Organized by Messe Düsseldorf (Shanghai) Co., Ltd., Medical Fair China (MFC) 2026 successfully concluded on August 22, 2026, at Suzhou International Expo Center. Under the theme “From Innovation to Application: Driving Medical Transformation and Global Expansion,” the exhibition brought together medical device companies, healthcare institutions, research organizations, industry associations and professionals from China and abroad.
This year, MFC brought together 320 medical device companies and innovative organizations, attracting 17,486 professional visitors, healthcare representatives, experts, academics and industry professionals over three days. The exhibition also saw a significant increase in international participation, with the number of overseas professional visitors and buyers doubling from the previous year and accounting for 6% of total attendance. Visitors from 48 countries and regions attended the show, including buyer groups from Germany, the UK, Australia, Canada, Kazakhstan, South Korea, India, Dubai, Malaysia, Indonesia and Romania. They met with Chinese medical device companies to discuss product procurement, market access, distribution partnerships and international business opportunities, providing more opportunities for Chinese companies to explore overseas markets.
As the only satellite event of MEDICA—the world’s largest medical trade fair—in China and a member of MEDICARE ASIA, MFC continues to leverage Messe Düsseldorf’s global healthcare industry network to facilitate international exchange and industry cooperation.
Ms. Evian Gu, General Manager of Messe Düsseldorf (Shanghai) Co., Ltd., said: “We are delighted to see that this year’s MFC has reached a new high in internationalization, which fully demonstrates the strong appeal of China’s medical device innovation to the global market. Looking ahead, MFC will continue to leverage its advantages as an international platform, further deepen international buyer outreach and market matchmaking services, help more Chinese companies efficiently connect with global opportunities, and accelerate the implementation and commercialization of more innovative outcomes, injecting new momentum into the mutual benefit and win-win development of the global medical industry.”
Driving Innovation from Concept to Application Across Specialized Zones
In 2026, MFC further enhanced its specialized zones to address the evolving needs of healthcare innovation and application. Covering key areas including in vitro diagnostics (IVD), home healthcare, medical manufacturing, minimally invasive and interventional technologies, and medical consumables, the exhibition brought together leading companies to showcase innovative technologies, products and solutions, highlighting the industry’s continued transition from innovation to real world application.
IVD Zone: From Precision Diagnostics to Multi-Scenario Applications
In vitro diagnostics (IVD) play a critical role in early disease screening, precision diagnosis and treatment decision-making. This year, MFC placed greater emphasis on its dedicated IVD Zone, bringing together more than 60 companies across molecular diagnostics, point-of-care testing (POCT), immunodiagnostics, biochemical testing, AI-assisted analysis and home testing. The zone showcased innovations spanning the spectrum from laboratory and clinical diagnostics to home health applications.
In precision and molecular diagnostics, Anbio Biotech, Nanjing Healed and HymonBio presented technologies and solutions for genetic testing, nucleic acid testing and precision diagnostics. In rapid and point-of-care testing, Drophil Biotech, Sun Biotech, QL Biotech and Anhui DeepBlue Medical Technology showcased solutions designed to improve testing efficiency and enable faster decision-making across diverse healthcare settings. Meanwhile, Getein Biotech, Kanghua Biotechnology, Human Metabolomics, Synsorbio, Hebei Xinle, Hangzhou Testsea, B&E, Sejoy, Bioland and Biobase featured intelligent testing technologies, laboratory equipment and related solutions.
Representative innovations on display further highlighted the expansion of IVD technologies toward greater precision, intelligence and home-based applications. These included Nanjing Healed’s four-in-one circular RNA test kit for depression and Sejoy’s new-generation 4G cloud-based smart blood glucose meter, demonstrating how IVD innovation is evolving across different application scenarios, from precision diagnostics to digital health management.
Home Healthcare Zone: Bringing Healthcare from Hospitals into the Home
As population ageing, chronic disease management and demand for home-based healthcare continue to grow, MFC placed greater emphasis on the home healthcare sector, covering health monitoring, home care, rehabilitation and health management. Companies including Zepu, Hanvon Health, Pango, Lumi, Jinfu, Aofeite, Lifemed, Berrcom, Exanovo and ADSS, as well as Pioneer, showcased a diverse range of products and solutions designed to support healthcare beyond traditional clinical settings.
Exhibitors showcased innovative solutions for health monitoring, home care and rehabilitation, supporting more convenient everyday health management. The zone highlighted the continued expansion of healthcare services beyond hospitals into homes and communities, reflecting the industry’s growing focus on real-world needs and applications.
Medical Manufacturing Zone: Advanced Manufacturing Enabling Medical Device Innovation
Innovation in medical devices depends not only on end products, but also on advances in precision manufacturing, critical components and materials. The MFC Medical Manufacturing Zone covered precision machining, smart manufacturing, advanced materials, fluid technology and critical components, bringing together companies including Chung Pak, Huayi Precision, AccuPath, Eco Polymer, Kamoer, Nisus, MISHPREC, Consensic and Zhejiang Hongchang Machinery.
Exhibitors showcased technologies in precision machining, medical materials, fluid control, automation and critical components, supporting greater precision, efficiency and stability in medical device manufacturing. The zone also highlighted the growing integration of advanced manufacturing with medical device R&D and production.
Meanwhile, the Minimally Invasive & Interventional Zone showcased innovative technologies and advanced medical devices for minimally invasive diagnosis and treatment. The Medical Consumables Zone featured a wide range of products for surgery, nursing, treatment and everyday healthcare, highlighting their role in enhancing clinical efficiency, supporting patient safety and improving healthcare delivery.
Many exhibitors noted that MFC offered more than a platform for showcasing innovation, providing valuable opportunities to connect directly with healthcare institutions, research organizations, distributors and international buyers.
Xu Zheng, Head of the Kunshan Service Center at LINGKE ULTRASONICS, said: “MFC offers a professional atmosphere and brings together well-matched exhibitors and visitors. It gave us a valuable opportunity to meet industry customers and potential partners, while gaining a better understanding of market needs and trends. We look forward to continuing our involvement in MFC and collaborating with more industry partners in the future.”
Cheng Wenhui, Head of International Marketing at Shandong Ande Health, said: “MFC is an important link between Chinese innovation and international markets. The show gave us a good opportunity to present our products and meet overseas customers. We hope to reach more international markets through MFC.”
From exhibitors to professional visitors, MFC provided a valuable opportunity for both sides of the industry to meet face to face and gain a better understanding of the market. Mehrad, Purchasing Manager at Lian Trade, Iran, said: “This was my first time at Medical Fair China in Suzhou, and I was impressed by the wide range of medical device products. The show gave me a good opportunity to meet Chinese companies and explore potential cooperation.”
High-Level Concurrent Events Explore New Opportunities for Medical Innovation and Industry Development
Alongside the exhibition, MFC hosted a series of professional forums, seminars and industry events, bringing together 120 experts and speakers from healthcare institutions, research organizations, industry associations, medical technology companies and international markets, and attracting 1000 industry attendees. Discussions covered key topics including AI, wearable technologies, home healthcare, medical procurement, high-quality hospital development and international market expansion, strengthening connections between emerging technologies, clinical needs and real-world applications.
As a key event dedicated to the future of healthcare innovation, the 2026 FTR4H – Future for Healthcare Forum, organized by Wearable Technology AG, brought together experts and industry representatives from China and abroad to explore AI and data analytics, wearable technologies and home healthcare. Dr. Iyappan Gunasekaran from the for Cardiovascular Health Engineering (COCHE), Hong Kong, shared insights into the application of AI and data technologies in healthcare, while Eric Zhang from Haleon discussed developments in health technology. Speakers from Yisheng Innovation Technology, AP Infosense, Solventum and Bosch, among others, shared perspectives on digital health, wearables, healthcare data and innovative applications. Through keynote presentations and panel discussions, the forum explored how AI, sensors and digital technologies can drive innovation in healthcare delivery and accelerate the transition from technology development to real-world applications.
Addressing international healthcare markets and the global expansion of Chinese medical device companies, the Kazakhstan Medical Procurement Forum brought together healthcare and procurement representatives to discuss market demand, medical device procurement and international cooperation. Ali Nurgozhayev, Director of the Institute of Health Economics and Financing, and Assem Imandossova, Executive Director of the Kazakhstan Healthcare Managers Association, shared insights into the Kazakh healthcare market and procurement landscape. The forum also facilitated direct dialogue between international buyers and Chinese companies on market access, product demand and potential partnerships, supporting business expansion in Central Asia.
As innovation increasingly connects technology development with clinical practice, the 2nd Seminar on Empowering High-Quality Hospital Development through Innovative Technologies, organized by the China Association for the Promotion of Rehabilitation Technology Transformation and Development, focused on hospital discipline development under the 15th Five-Year Plan, medical technology innovation and research translation. Discussions explored how innovative technologies can better address clinical needs and accelerate the adoption of new solutions, while strengthening collaboration among hospitals, research institutions and medical device companies.
In addition, the 2026 Emergency Medical Alliance Series – Empowering Integrated Medical and Elderly Care through Fine Medical-Engineering Management, hosted by the Chinese Hospital Association and supported by Messe Düsseldorf (Shanghai), was held concurrently in Hall A. Hospital and healthcare professionals discussed medical-engineering collaboration, refined management and integrated medical and elderly care. Their participation further reflected MFC’s strong reach among targeted professional audiences, particularly healthcare institutions, providing more direct connections between medical device companies and end users.
From future healthcare technologies and international medical procurement to home testing, consumer healthcare and hospital innovation, MFC’s concurrent events brought together professionals from across the healthcare industry. Attendees also praised the practical value of the forums. Mrs. Yuan, Deputy Director of Operations at Jianxin Medical, said: “The forum covered timely topics and gave us useful insights into healthcare supply chains and new ideas for future cooperation.”
The exhibition and forums together connected innovation, clinical needs, industry applications and global markets, supporting the adoption of new technologies and closer industry collaboration.
With MFC 2026 now concluded, the exhibition not only showcased the latest innovations in medical technology, but also strengthened connections between technological innovation, clinical applications, industry collaboration and international cooperation, providing a professional and efficient platform for Chinese and international medical device companies to explore partnerships and share new opportunities.
The next edition of Medical Fair China (MFC 2027) will take place on August 19-21, 2027, at Suzhou International Expo Center. MFC looks forward to once again bringing together partners from across the global healthcare industry, showcasing more cutting-edge technologies and innovative solutions, and exploring new pathways from innovation to application.
Meanwhile, MEDICA 2026, the world’s leading medical trade fair, will take place from November 16 to19, 2026, in Düsseldorf, Germany. The global medical community will gather there to exchange insights on emerging trends and forge new pathways for international cooperation.
